Federico Roncaroli, Carmine Antonio Donofrio, Liam Walker, Roger Laitt, Chiara Villa, Waseem Majeed
{"title":"垂体神经内分泌肿瘤的最新分类和诊断方法","authors":"Federico Roncaroli, Carmine Antonio Donofrio, Liam Walker, Roger Laitt, Chiara Villa, Waseem Majeed","doi":"10.1016/j.mpdhp.2024.10.001","DOIUrl":null,"url":null,"abstract":"<div><div>Tumours of the anterior pituitary account for around 20% of intracranial neoplasms and are the most common tumours of the entire neuroendocrine system, representing a sizeable proportion of the diagnostic workload for specialist pituitary centres. The 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours (ENDO5) introduced changes to the classification of adenohypophyseal cell tumours including the nomenclature of pituitary neuroendocrine tumours (PitNET), the introduction of an ICD-O code for malignancy, and the term ‘metastatic PitNET’ to replace pituitary carcinoma, and further emphasis in the diagnostic use of lineage restricted transcription factors. ENDO5 did not mention any progress in the molecular profiling of PitNETs or any proposal to identify PitNETs with aggressive potential. This review aims to appraise the changes introduced in ENDO5 and provide practical suggestions to interpret the classification of PitNETs and to their diagnostic approach.</div></div>","PeriodicalId":39961,"journal":{"name":"Diagnostic Histopathology","volume":"30 12","pages":"Pages 668-679"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Update on the classification and diagnostic approach of pituitary neuroendocrine tumours\",\"authors\":\"Federico Roncaroli, Carmine Antonio Donofrio, Liam Walker, Roger Laitt, Chiara Villa, Waseem Majeed\",\"doi\":\"10.1016/j.mpdhp.2024.10.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Tumours of the anterior pituitary account for around 20% of intracranial neoplasms and are the most common tumours of the entire neuroendocrine system, representing a sizeable proportion of the diagnostic workload for specialist pituitary centres. The 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours (ENDO5) introduced changes to the classification of adenohypophyseal cell tumours including the nomenclature of pituitary neuroendocrine tumours (PitNET), the introduction of an ICD-O code for malignancy, and the term ‘metastatic PitNET’ to replace pituitary carcinoma, and further emphasis in the diagnostic use of lineage restricted transcription factors. ENDO5 did not mention any progress in the molecular profiling of PitNETs or any proposal to identify PitNETs with aggressive potential. This review aims to appraise the changes introduced in ENDO5 and provide practical suggestions to interpret the classification of PitNETs and to their diagnostic approach.</div></div>\",\"PeriodicalId\":39961,\"journal\":{\"name\":\"Diagnostic Histopathology\",\"volume\":\"30 12\",\"pages\":\"Pages 668-679\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diagnostic Histopathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756231724001543\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostic Histopathology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756231724001543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Update on the classification and diagnostic approach of pituitary neuroendocrine tumours
Tumours of the anterior pituitary account for around 20% of intracranial neoplasms and are the most common tumours of the entire neuroendocrine system, representing a sizeable proportion of the diagnostic workload for specialist pituitary centres. The 5th edition WHO Classification of Endocrine and Neuroendocrine Tumours (ENDO5) introduced changes to the classification of adenohypophyseal cell tumours including the nomenclature of pituitary neuroendocrine tumours (PitNET), the introduction of an ICD-O code for malignancy, and the term ‘metastatic PitNET’ to replace pituitary carcinoma, and further emphasis in the diagnostic use of lineage restricted transcription factors. ENDO5 did not mention any progress in the molecular profiling of PitNETs or any proposal to identify PitNETs with aggressive potential. This review aims to appraise the changes introduced in ENDO5 and provide practical suggestions to interpret the classification of PitNETs and to their diagnostic approach.
期刊介绍:
This monthly review journal aims to provide the practising diagnostic pathologist and trainee pathologist with up-to-date reviews on histopathology and cytology and related technical advances. Each issue contains invited articles on a variety of topics from experts in the field and includes a mini-symposium exploring one subject in greater depth. Articles consist of system-based, disease-based reviews and advances in technology. They update the readers on day-to-day diagnostic work and keep them informed of important new developments. An additional feature is the short section devoted to hypotheses; these have been refereed. There is also a correspondence section.